Literature DB >> 21195923

The effect of obesity on chronic kidney disease.

Joel D Kopple1, Usama Feroze.   

Abstract

Overweightness and obesity are associated with many hemodynamic, structural, and histopathologic alterations in the kidney and with metabolic and biochemical changes that predispose to these abnormalities. Consequent to these disorders, these individuals are more likely to develop chronic kidney disease and end-stage renal failure. Overweight and obese people are more prone to develop albuminuria and, for at least some types of kidney disease, a greater amount of albuminuria and more rapid progression of renal failure. These individuals are more likely to develop diabetes mellitus and hypertension. Diabetic nephropathy, hypertensive nephrosclerosis, focal and segmental glomerulosclerosis, renal cell carcinoma, and urate and calcium oxalate urolithiasis are the more common kidney and urological diseases reported in obese people. Preliminary data indicate that many of the clinical and nephropathologic manifestations associated with obesity can be reversed or ameliorated with reductions in body fat induced by dietary energy restriction or surgical procedures that reduce intake and gastrointestinal absorption of calories.
Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21195923     DOI: 10.1053/j.jrn.2010.10.009

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  18 in total

Review 1.  The Kidney: An Organ in the Front Line of Oxidative Stress-Associated Pathologies.

Authors:  Yves Gorin
Journal:  Antioxid Redox Signal       Date:  2016-08-01       Impact factor: 8.401

2.  Correlation of ultrasonographic measurement of intrarenal arterial resistance index with microalbuminuria in nonhypertensive, nondiabetic obese patients.

Authors:  Fang Han; Ningning Hou; Wei Miao; Xiaodong Sun
Journal:  Int Urol Nephrol       Date:  2012-10-09       Impact factor: 2.370

3.  Bariatric Surgery Is Protective Against Renal Function Decline in Severely Obese Patients in the Long-Term.

Authors:  Anne Lautenbach; Jan-Wilhelm Wienecke; Fabian Stoll; Nina Riedel; Oliver Mann; Tobias B Huber; Philipp Busch; Jens Aberle
Journal:  Obes Surg       Date:  2020-11-07       Impact factor: 4.129

4.  Body mass index is an independent predictive factor for kidney function evaluated by glomerular filtration rate in a community-dwelling population.

Authors:  Yuanyuan Duan; Xiaona Wang; Jiao Zhang; Ping Ye; Ruihua Cao; Xu Yang; Yongyi Bai; Hongmei Wu
Journal:  Eat Weight Disord       Date:  2017-09-04       Impact factor: 4.652

Review 5.  Obesity in kidney disease: A heavyweight opponent.

Authors:  Raphael Jose Ferreira Felizardo; Marina Burgos da Silva; Cristhiane Favero Aguiar; Niels Olsen Saraiva Câmara
Journal:  World J Nephrol       Date:  2014-08-06

Review 6.  Contextual poverty, nutrition, and chronic kidney disease.

Authors:  Orlando M Gutiérrez
Journal:  Adv Chronic Kidney Dis       Date:  2015-01       Impact factor: 3.620

7.  Perirenal fat associated with microalbuminuria in obese rats.

Authors:  Ningning Hou; Fang Han; Mingling Wang; Na Huang; Jiangang Zhao; Xue Liu; Xiaodong Sun
Journal:  Int Urol Nephrol       Date:  2014-02-13       Impact factor: 2.370

8.  Association between syndecan-1 and renal function in adolescents with excess weight: evidence of subclinical kidney disease and endothelial dysfunction.

Authors:  Z M R M Saboia; G C Meneses; A M C Martins; E F Daher; G B Silva Junior
Journal:  Braz J Med Biol Res       Date:  2018-01-11       Impact factor: 2.590

9.  Effect of pentoxifylline on microalbuminuria in diabetic patients: a randomized controlled trial.

Authors:  Shahrzad Shahidi; Marziyeh Hoseinbalam; Bijan Iraj; Mojtaba Akbari
Journal:  Int J Nephrol       Date:  2015-03-22

10.  Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort.

Authors:  Xia Cao; Jiansong Zhou; Hong Yuan; Liuxin Wu; Zhiheng Chen
Journal:  BMC Nephrol       Date:  2015-06-18       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.